Johnathan Man
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 5
- PARP inhibition in cancer therapy 1
- Pancreatic and Hepatic Oncology Research 1
- Global Cancer Incidence and Screening 1
-
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Chee Khoon Lee (6 shared papers)Matthew Links (4 shared papers)Val Gebski (4 shared papers)Tony Mok (2 shared papers)James Chih‐Hsin Yang (2 shared papers)Richard J. Gralla (1 shared paper)Wendy A. Cooper (1 shared paper)Roy S. Herbst (1 shared paper)
In The Last Decade
Johnathan Man
10 papers receiving 1.2k citations
Johnathan Man's Hit Papers
Peers
Comparison fields: 5 of 55
- Oncology 826
- Pulmonary and Respiratory Medicine 611
- Cancer Research 130
- Immunology 119
- Pathology and Forensic Medicine 31
Countries citing papers authored by Johnathan Man
This map shows the geographic impact of Johnathan Man's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johnathan Man with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johnathan Man more than expected).
Fields of papers citing papers by Johnathan Man
This network shows the impact of papers produced by Johnathan Man. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johnathan Man. The network helps show where Johnathan Man may publish in the future.
Co-authors
The 25 scholars most cited alongside Johnathan Man, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Checkpoint Inhibitors in Metastatic EGFR- Mutated Non–Small Cell Lung Cancer—A Meta-Analysis Hit paper breakdown → | 2016 | 597 |
| 2 | Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non–Small Cell Lung Carcinoma Hit paper breakdown → | 2017 | 421 |
| 3 | 2018 | 86 | |
| 4 | 2018 | 37 | |
| 5 | 2021 | 24 | |
| 6 | 2019 | 8 | |
| 7 | 2017 | 4 | |
| 8 | 2017 | 2 | |
| 9 | 2016 | 2 | |
| 10 | 2017 | 1 | |
| 11 | 2016 | 0 |
About Johnathan Man
Johnathan Man is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Issues, ethics and legal aspects, Epidemiology and Reproductive Medicine, having authored 11 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (2 papers), PARP inhibition in cancer therapy (1 paper), Nursing Diagnosis and Documentation (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Cancer Genomics and Diagnostics (1 paper), Statistical Methods in Clinical Trials (1 paper) and Global Cancer Incidence and Screening (1 paper). The work is most often cited by research in Oncology (826 citations), Pulmonary and Respiratory Medicine (611 citations), Cancer Research (130 citations), Immunology (119 citations) and Pathology and Forensic Medicine (31 citations). Johnathan Man has collaborated with scholars based in Australia, Hong Kong and Taiwan. Frequent co-authors include Chee Khoon Lee, Matthew Links, Val Gebski, Tony Mok, James Chih‐Hsin Yang, Richard J. Gralla, Wendy A. Cooper, Roy S. Herbst, G. Ritchie and Michael Friedländer. Their work appears in journals such as Journal of Thoracic Oncology, JAMA Oncology, Annals of Oncology, JNCI Cancer Spectrum and npj Primary Care Respiratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.